Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: May 21, 2018

DrugPatentWatch Database Preview

Able Company Profile

« Back to Dashboard

What is the competitive landscape for ABLE, and what generic and branded alternatives to ABLE drugs are available?

ABLE has sixty-two approved drugs.

Summary for Able

US Patents:	0
Tradenames:	27
Ingredients:	27
NDAs:	62
Patent Litigation for Able:	See patent lawsuits for Able

Drugs and US Patents for Able

+ Get email alerts for changes to this table

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Able	SULFAMETHOXAZOLE AND TRIMETHOPRIM AND PHENAZOPYRIDINE HYDROCHLORIDE	phenazopyridine hydrochloride; sulfamethoxazole; trimethoprim	TABLET;ORAL	021105-001	Jun 26, 2001		DISCN	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Able	METHYLPHENIDATE HYDROCHLORIDE	methylphenidate hydrochloride	TABLET, EXTENDED RELEASE;ORAL	076032-001	May 9, 2001		DISCN	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Able	PROMETHAZINE HYDROCHLORIDE	promethazine hydrochloride	SUPPOSITORY;RECTAL	040504-002	Apr 11, 2003		DISCN	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Able	HYDROCODONE BITARTRATE AND ACETAMINOPHEN	acetaminophen; hydrocodone bitartrate	TABLET;ORAL	040464-001	Oct 23, 2002		DISCN	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Able

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance

McKesson

Chinese Patent Office

Cerilliant

Accenture

Cipla

McKinsey

Fuji

Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.